The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma

In recent years, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced as a therapeutic option in the treatment of several congenital and acquired craniofacial defects. Although there have been promising clinical results, the international literature still lacks complete guide...

Descripción completa

Detalles Bibliográficos
Autor principal: Herford, A.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343095/
https://www.ncbi.nlm.nih.gov/pubmed/28236566
http://dx.doi.org/10.1016/j.cjtee.2016.05.004
_version_ 1782513304687607808
author Herford, A.S.
author_facet Herford, A.S.
author_sort Herford, A.S.
collection PubMed
description In recent years, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced as a therapeutic option in the treatment of several congenital and acquired craniofacial defects. Although there have been promising clinical results, the international literature still lacks complete guidelines, including limits and indications for the use of rhBMP-2. The possible indications for rhBMP-2 in patients undergoing facial trauma are discussed in this article.
format Online
Article
Text
id pubmed-5343095
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-53430952017-03-17 The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma Herford, A.S. Chin J Traumatol Review Article In recent years, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced as a therapeutic option in the treatment of several congenital and acquired craniofacial defects. Although there have been promising clinical results, the international literature still lacks complete guidelines, including limits and indications for the use of rhBMP-2. The possible indications for rhBMP-2 in patients undergoing facial trauma are discussed in this article. Elsevier 2017-02 2017-02-09 /pmc/articles/PMC5343095/ /pubmed/28236566 http://dx.doi.org/10.1016/j.cjtee.2016.05.004 Text en © 2017 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Herford, A.S.
The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
title The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
title_full The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
title_fullStr The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
title_full_unstemmed The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
title_short The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
title_sort use of recombinant human bone morphogenetic protein-2 (rhbmp-2) in maxillofacial trauma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343095/
https://www.ncbi.nlm.nih.gov/pubmed/28236566
http://dx.doi.org/10.1016/j.cjtee.2016.05.004
work_keys_str_mv AT herfordas theuseofrecombinanthumanbonemorphogeneticprotein2rhbmp2inmaxillofacialtrauma
AT herfordas useofrecombinanthumanbonemorphogeneticprotein2rhbmp2inmaxillofacialtrauma

Ejemplares similares